Know Cancer

or
forgot password

Korean's Practice Patterns for Screening PCA(Prostate Cancer) According to PSA(Prostate-specific Antigen) Level


N/A
40 Years
N/A
Not Enrolling
Male
Neoplasms, Prostate, Prostate Cancer, Benign Prostatic Hyperplasia

Thank you

Trial Information

Korean's Practice Patterns for Screening PCA(Prostate Cancer) According to PSA(Prostate-specific Antigen) Level


This is to investigate Korean urologist's practice patterns for screening prostate cancer
according to PSA level.


Inclusion Criteria:



- Male with PSA more than 2.5ng/ml from 1 Jan 2008 to 31 Dec 2008

Exclusion Criteria:

- Age less than 40 at PSA screening

- History of drug use which can affect level of PSA within 6months before PSA screening

- Subject who participate any other clinical trial

Type of Study:

Observational

Study Design:

Time Perspective: Retrospective

Outcome Measure:

Number of subjects with prostate biopsy

Outcome Time Frame:

1year

Safety Issue:

No

Principal Investigator

GSK Clinical Trials

Investigator Role:

Study Director

Investigator Affiliation:

GlaxoSmithKline

Authority:

Korea: Institutional Review Board

Study ID:

113951

NCT ID:

NCT01371513

Start Date:

May 2010

Completion Date:

June 2011

Related Keywords:

  • Neoplasms, Prostate
  • Prostate Cancer
  • Benign Prostatic Hyperplasia
  • Serum prostate specific antigen
  • Prostatic Hyperplasia
  • Neoplasms
  • Hyperplasia
  • Prostatic Neoplasms

Name

Location